Sustainability & Climate

As Option Care Health preps its Q1 results, investors watch if it can seize market share from a retreating rival while navigating major biosimilar headwinds.

With its reputation on the line, SF's top leaders are gathering for IDEASF, a new forum aiming to spark a city-wide renaissance. But can it deliver results?

A new nonprofit is using crypto transaction fees to fight childhood hunger, partnering with Feed the Children in a bold new experiment for philanthropy.

The global food expo leader is launching in Vietnam, tapping into Asia's new powerhouse to help diversify and strengthen fragile global supply chains.

Jordan Foster Construction's latest award reveals a deeper trend: integrating mental health and AI to redefine safety in a high-risk industry.

Brazilian importers bypass high local credit costs using a Chinese state-backed insurance, unlocking cash flow and fueling a new wave of trade growth.

A single-dose therapy wiped out aggressive glioblastoma tumors in a landmark pre-clinical study, paving the way for human trials in 2026.

Ex-Global X exec Rob Oliver launches Aura ETFs. Its first fund, DUTY, taps into defense spending and donates 10% of fees to military veteran charities.

With most OUD patients lacking access to care, a new grant funds research into payment models that reward results, not just services.

A new class-action lawsuit claims Michigan fails its constitutional duty to Detroit students, igniting a battle over systemic funding and educational rights.

In 2025, a non-profit delivered 53,000 hours of free virtual programs, from pet painting to yoga, creating a new blueprint for aging well.

The energy tech giant completes its EMEA business divestiture to AURELIUS, sharpening focus on the Americas and APAC while reshaping Europe's grid market.

A new clinical trial is underway for a next-gen aortic valve, promising a less invasive procedure and improved durability for millions of patients.

Reykjavík's premier music festival returns with a stellar first wave, promising unique shows from The Streets, Shygirl, and Daði Freyr with an orchestra.

The nation's top farm co-op faces mounting losses from biofuel rules and weak grain markets, signaling wider distress across the American heartland.

Retired NASA astronaut and UMD alumna Dr. Jeanette Epps will inspire the Class of 2026, bringing her story of 'fearless determination' back to campus.

With stellar trial data for its cholesterol drug obicetrapib, NewAmsterdam Pharma faces investors as it navigates a competitive market and awaits key results.

As Spectral AI preps its revolutionary DeepView wound scanner for launch, new CFO David McGuire brings crucial public company expertise to a pivotal transition.

Ovid Therapeutics is spotlighting a novel drug class targeting KCC2, a key brain protein. Could this be the key to treating psychosis and epilepsy?

Asher House Wellness becomes Lillie&Lee, leveraging its founder's viral rescue fame to build a transparent wellness empire for both pets and people.